DSS-18901-55787
3 vaccinations
11 coded responses
26 check-ins
11 free-text entries
4 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 030 / NH
- Registered
- 2021-01-05
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-01-05
Registered in v-safe
-
2021-01-05
Dose 1 — Moderna
-
2021-01-06
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Pain, Swelling · Fatigue or tirednessAdult check-in
- 2021-01-07
-
2021-01-08
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Fever · Chills, Fatigue or tiredness, Nausea · Be unable to do your normal daily activitiesAdult check-in
-
2021-01-08
Report sent to call center — days 1–6 daily, dose 1Be unable to do your normal daily activities1 call case(s)
- 2021-01-09
-
2021-01-11
Survey response — days 1–6 daily, dose 1MedDRA: Depression — Feeling: Fair · Fatigue or tiredness · Be unable to do your normal daily activitiesFree text: DepressionMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-11
Report sent to call center — days 1–6 daily, dose 1Be unable to do your normal daily activities1 call case(s)
- 2021-01-12
- 2021-01-19
- 2021-01-26
-
2021-02-02
Survey response — day 28, dose 1MedDRA: Abdominal discomfort — Feeling: FairFree text: daily GI upsetMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-02-03
Dose 2 — Moderna
-
2021-02-03
Survey response — day 0, dose 2MedDRA: Dizziness — Feeling: Fair · Site: Pain · Fever · Chills, Fatigue or tiredness · Be unable to do your normal daily activitiesFree text: DizzinessMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-02-04
Survey response — days 1–6 daily, dose 2MedDRA: Dizziness — Feeling: Poor · Site: Pain, Redness, Swelling · Fever · Chills, Fatigue or tiredness, Nausea · Be unable to work, Be unable to do your normal daily activitiesFree text: DizzinessMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-02-05
Survey response — days 1–6 daily, dose 2MedDRA: Flushing — Feeling: Poor · Site: Pain, Redness, Swelling · Fever · Fatigue or tiredness, Nausea · Be unable to work, Be unable to do your normal daily activitiesFree text: FlushingMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-02-06
Survey response — days 1–6 daily, dose 2MedDRA: Muscle spasms — Feeling: Fair · Site: Redness · Fatigue or tiredness · Be unable to workFree text: Muscle spasmsMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-02-07
Survey response — days 1–6 daily, dose 2MedDRA: Hyperhidrosis — Feeling: Fair · Chills, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to work, Be unable to do your normal daily activitiesFree text: SweatingMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-02-08
- 2021-02-09
- 2021-02-10
-
2021-02-17
Survey response — day 14, dose 2MedDRA: Fungal skin infection, Upper respiratory tract infection, Urinary tract infection — Feeling: Fair · Be unable to work, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Developed a urinary tract infection and concurrent yeast infection of the genital skin. Currently experiencing an upper respiratory infection, non-Covid-19.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-02-17
Report sent to call center — day 14, dose 2Be unable to work · Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional1 call case(s)
- 2021-02-24
- 2021-03-05
- 2021-03-12
-
2021-03-17
Survey response — day 42, dose 2MedDRA: Fatigue, Myalgia — Feeling: Good · Be unable to work, Be unable to do your normal daily activitiesFree text: Muscle aches and fatigueMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-05-05
-
2021-07-25
Call successfulCompleted over the phone
-
2021-08-05
Survey response — 6 months, dose 2MedDRA: Abortion missed, Surgery — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit, HospitalizationFree text: Symptoms: A missed abortion · Healthcare visit (other): Outpatient surgeryMedDRA releases: 2021-09,2024-11 · check-in free text available
-
2021-08-05
Report sent to call center — 6 months, dose 2Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr1 call case(s)
-
2022-01-13
Dose 3 — Pfizer-BioNTech
-
2022-02-04
Survey response — 12 months, dose 2MedDRA: Pregnancy — Feeling: GoodFree text: PregnancyMedDRA releases: 2024-11 · check-in free text available
- 2022-07-14
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-05 | Moderna | |
| 2 | 2021-02-03 | Moderna | |
| 3 | 2022-01-13 | Pfizer-BioNTech | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2021-01-08 | priority 2/3 | |
| 2021-01-11 | priority 2/3 | |
| 2021-02-17 | Successful 2021-07-25 |
Completed over the phone |
| 2021-08-05 | Successful | Reported to VAERS during previous contact from GDIT |
Free text
Release 1 — days 1–6 daily, dose 1
Systemic reaction (other): Depression
Release 3 — day 28, dose 1
Symptoms: daily GI upset
Release 3 — day 0, dose 2
Systemic reaction (other): Dizziness
Release 3 — days 1–6 daily, dose 2
Systemic reaction (other): Dizziness
Systemic reaction (other): Flushing
Systemic reaction (other): Muscle spasms
Systemic reaction (other): Sweating
Release 4 — day 14, dose 2
Symptoms: Developed a urinary tract infection and concurrent yeast infection of the genital skin. Currently experiencing an upper respiratory infection, non-Covid-19.
Release 5 — day 42, dose 2
Symptoms: Muscle aches and fatigue
Release 9 — 6 months, dose 2
Release 11 — 12 months, dose 2
Symptoms: Pregnancy
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Surgery | ✓ | · | ✓ |
| SD | Abdominal discomfort | ✓ | ✓ | ✓ |
| SD | Abortion missed | ✓ | · | ✓ |
| SD | Fatigue | ✓ | ✓ | ✓ |
| SD | Fungal skin infection | ✓ | ✓ | ✓ |
| SD | Myalgia | ✓ | ✓ | ✓ |
| SD | Pregnancy | · | · | ✓ |
| SD | Upper respiratory tract infection | ✓ | ✓ | ✓ |
| SD | Urinary tract infection | ✓ | ✓ | ✓ |
| SRO | Depression | ✓ | ✓ | ✓ |
| SRO | Dizziness | ✓ | ✓ | ✓ |
| SRO | Flushing | ✓ | ✓ | ✓ |
| SRO | Hyperhidrosis | ✓ | ✓ | ✓ |
| SRO | Muscle spasms | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release